AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO)

Q: What does CUSIP 00847X104 represent in this 13F holders report?

CUSIP 00847X104 is the security identifier for AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share in Q4 2020?

189 institutional investors reported AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share for Q4 2020. Use the holders table for investor-level position and value details.

CUSIP: 00847X104

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class: Equity / Common Stock, Par Value $0.001 per share
Shares outstanding: 59,431,072
Total 13F shares: 64,981,734
Share change: -843,732
Total reported value: $2,817,090,446
Put/Call ratio: 122%
Price per share: $43.33
Number of holders: 189
Value change: -$19,419,372
Number of buys: 87
Number of sells: 112

Quarterly Holders Quick Answers

What is CUSIP 00847X104?
CUSIP 00847X104 identifies AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2021
Previous quarter: Q3 2020

Recent filing periods for CUSIP 00847X104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	13%	7,910,208	$276,857,000	—	30 Sep 2020	13F
VANGUARD GROUP INC	13F	Company	9.3%	5,508,177	$192,785,000	—	30 Sep 2020	13F
BlackRock Finance, Inc.	13F	Company	8.1%	4,795,138	$167,829,000	—	30 Sep 2020	13F
Bellevue Group AG	13F	Company	7%	4,151,002	$145,286,000	—	30 Sep 2020	13F
FMR LLC	13F	Company	6.4%	3,828,886	$134,011,000	—	30 Sep 2020	13F
Capital International Investors	13F	Company	5.8%	3,435,353	$120,237,000	—	30 Sep 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	5.2%	3,109,609	$108,836,000	—	30 Sep 2020	13F
ORBIMED ADVISORS LLC	13F	Company	3.7%	2,207,321	$77,256,000	—	30 Sep 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	3.7%	2,192,489	$76,737,000	—	30 Sep 2020	13F
STATE STREET CORP	13F	Company	3.5%	2,067,022	$72,346,000	—	30 Sep 2020	13F
FIRST TRUST ADVISORS LP	13F	Company	3%	1,805,542	$63,194,000	—	30 Sep 2020	13F
Casdin Capital, LLC	13F	Company	2.9%	1,750,000	$61,250,000	—	30 Sep 2020	13F
JPMORGAN CHASE & CO	13F	Company	2.7%	1,627,399	$55,983,000	—	30 Sep 2020	13F
Rock Springs Capital Management LP	13F	Company	2.7%	1,581,509	$55,353,000	—	30 Sep 2020	13F
MACQUARIE GROUP LTD	13F	Company	2.1%	1,234,135	$43,194,000	—	30 Sep 2020	13F
Clearbridge Investments, LLC	13F	Company	1.8%	1,087,278	$38,055,000	—	30 Sep 2020	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	1.8%	1,083,429	$37,920,000	—	30 Sep 2020	13F
ArrowMark Colorado Holdings LLC	13F	Company	1.8%	1,081,824	$37,864,000	—	30 Sep 2020	13F
Erste Asset Management GmbH	13F	Company	1.7%	987,500	$34,484,800	—	30 Sep 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.2%	707,021	$24,745,000	—	30 Sep 2020	13F
NORGES BANK	13F	Company	0.94%	557,625	$19,517,000	—	30 Sep 2020	13F
Point72 Asset Management, L.P.	13F	Company	0.8%	477,852	$16,725,000	—	30 Sep 2020	13F
MORGAN STANLEY	13F	Company	0.75%	443,708	$15,532,000	—	30 Sep 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.74%	441,990	$15,469,000	—	30 Sep 2020	13F
BNP Paribas Asset Management Holding S.A.	13F	Company	0.69%	410,222	$14,358,000	—	30 Sep 2020	13F
GREAT LAKES ADVISORS, LLC	13F	Company	0.65%	386,890	$13,541,000	—	30 Sep 2020	13F
S.c.a. Candriam	13F	Individual	0.64%	377,605	$13,216,000	—	30 Sep 2020	13F
AXA S.A.	13F	Company	0.63%	375,416	$13,140,000	—	30 Sep 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.63%	373,074	$13,057,000	—	30 Sep 2020	13F
Man Group plc	13F	Company	0.61%	359,925	$12,597,000	—	30 Sep 2020	13F
JENNISON ASSOCIATES LLC	13F	Company	0.6%	357,111	$12,499,000	—	30 Sep 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	0.56%	335,670	$11,748,000	—	30 Sep 2020	13F
Artisan Partners Limited Partnership	13F	Company	0.56%	335,539	$11,744,000	—	30 Sep 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.55%	325,606	$11,395,000	—	30 Sep 2020	13F
NORTHERN TRUST CORP	13F	Company	0.49%	288,400	$10,094,000	—	30 Sep 2020	13F
THRIVENT FINANCIAL FOR LUTHERANS	13F	Company	0.44%	263,939	$9,238,000	—	30 Sep 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.44%	263,265	$9,215,000	—	30 Sep 2020	13F
Bank of New York Mellon Corp	13F	Company	0.41%	241,175	$8,441,000	—	30 Sep 2020	13F
CITIGROUP INC	13F	Company	0.37%	222,088	$7,772,000	—	30 Sep 2020	13F
Hood River Capital Management LLC	13F	Company	0.36%	213,900	$7,487,000	—	30 Sep 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.34%	202,431	$7,085,000	—	30 Sep 2020	13F
Tekla Capital Management LLC	13F	Company	0.31%	186,964	$6,544,000	—	30 Sep 2020	13F
Ghost Tree Capital, LLC	13F	Company	0.29%	175,000	$6,125,000	—	30 Sep 2020	13F
ZWJ INVESTMENT COUNSEL INC	13F	Company	0.29%	171,982	$6,019,000	—	30 Sep 2020	13F
PEREGRINE CAPITAL MANAGEMENT LLC	13F	Company	0.28%	164,315	$5,751,000	—	30 Sep 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.27%	161,621	$5,657,000	—	30 Sep 2020	13F
Cubist Systematic Strategies, LLC	13F	Company	0.25%	146,272	$5,120,000	—	30 Sep 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.25%	146,056	$5,113,000	—	30 Sep 2020	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.24%	142,059	$4,972,000	—	30 Sep 2020	13F
Swiss National Bank	13F	Company	0.24%	140,560	$4,920,000	—	30 Sep 2020	13F

Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO) as of Q4 2020

As of 31 Dec 2020, AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO) was held by 189 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 64,981,734 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., FMR LLC, Bellevue Group AG, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, Rock Springs Capital Management LP, Casdin Capital, LLC, and ORBIMED ADVISORS LLC. This page lists 190 institutional shareholders reporting positions in this security for the Q4 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders

206

Q4 2020 holders

189

Holder diff

-17

Investor	Q3 2020 Shares	Q4 2020 Shares	Share Diff	Share Chg %	Q3 2020 Value $	Q4 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.